Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InterMed Laboratories is an India-based pharmaceutical manufacturer and marketer focused on finished dosage formulations and branded generics for global markets. The company operates three manufacturing facilities in and around Chennai and markets a broad portfolio of more than 900 SKUs across over 40 therapeutic categories. Its capabilities span tablets, capsules, oral liquids, ointments, dry syrups, and hydrogel transdermal patches, an area where the company states it was an early pioneer in India. InterMed primarily appears to be a commercial-stage formulations company rather than a clinical-stage drug developer, supplying government and private markets across Africa, Asia, Latin America, the CIS, Oceania, and the United States. The business combines formulation development, manufacturing, export distribution, and market expansion services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intermed Pharmaceuticals.